Baxter strives to settle while Spain plans to sue
This article was originally published in Clinica
Spain has reiterated its intention to sue Baxter Healthcare in the US for damages related to deaths linked to its Althane dialysers at three hospitals during the summer of 2001. Meanwhile, the company, having settled with all the Spanish families involved, is continuing to discuss compensation arrangements in other countries.
You may also be interested in...
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.
As interest in immune/inflammatory disease increases and savings achieved dip, payer focus on patient-reported outcomes for contracts reflects shift in focus, Avalere survey suggests.